Stellate Ganglion Block to Treat Long COVID 19 Case Series

Purpose

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Conditions

  • Long COVID
  • Long Covid19
  • Post-COVID-19 Syndrome
  • Post Acute COVID-19 Syndrome
  • Dysautonomia
  • Anosmia
  • Dysgeusia
  • Brain Fog
  • Muscle Pain
  • Shortness of Breath
  • Dizziness
  • Fatigue Post Viral
  • Cough
  • Menstrual Cycle Abnormal
  • Pain

Eligibility

Eligible Ages
All ages
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

People who scheduled themselves for a SGB in our clinics in Colorado. -

Exclusion Criteria

Stellate Ganglion Block Contraindications -

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Arm Groups

ArmDescriptionAssigned Intervention
SGB Patients for Long COVID 19 Patients who received ultrasound guided Stellate Ganglion block for symptoms of Long COVID in our Colorado clinics.
  • Procedure: Stellate Ganglion Block
    Ultrasound guided block of the Stellate Ganglion with local anesthetics.
    Other names:
    • SGB

Recruiting Locations

More Details

NCT ID
NCT05812209
Status
Completed
Sponsor
Metamorphosis LTD

Detailed Description

We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and 89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19 Syndrome. The patients were from the United States and received treatment at our Colorado clinics during the period of September to December 2022.Those who responded to our post-procedure follow-up calls were included in the study population.